ALPHARX INC
10SB12G, EX-27, 2000-06-16
Previous: ALPHARX INC, 10SB12G, EX-3.1, 2000-06-16
Next: MEDICHEM LIFE SCIENCES INC, S-1, 2000-06-16



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                                 <C>                     <C>                     <C>
<PERIOD-TYPE>                            12-MOS                  12-MOS                  6-MOS
<FISCAL-YEAR-END>                   SEP-30-1998             SEP-30-1999             SEP-30-2000
<PERIOD-END>                        SEP-30-1998             SEP-30-1999             MAR-31-2000
<CASH>                                  128,510                   1,562                   5,395
<SECURITIES>                                  0                  46,408                  46,408
<RECEIVABLES>                             1,621                       0                       0
<ALLOWANCES>                                  0                       0                       0
<INVENTORY>                                   0                       0                       0
<CURRENT-ASSETS>                        130,131                   1,562                   5,395
<PP&E>                                    7,301                   3,235                  13,848
<DEPRECIATION>                            2,460                   6,526                   8,904
<TOTAL-ASSETS>                          137,432                  51,205                  65,651
<CURRENT-LIABILITIES>                    36,136                  19,026                  34,722
<BONDS>                                       0                       0                       0
                         0                       0                       0
                                   0                       0                       0
<COMMON>                                  4,083                   4,228                   4,713
<OTHER-SE>                              101,296                  32,179                  30,929
<TOTAL-LIABILITY-AND-EQUITY>            137,432                  51,205                  65,651
<SALES>                                       0                       0                       0
<TOTAL-REVENUES>                         11,323                   3,725                     913
<CGS>                                         0                       0                       0
<TOTAL-COSTS>                                 0                       0                       0
<OTHER-EXPENSES>                       (225,055)               (800,842)               (115,506)
<LOSS-PROVISION>                              0                       0                       0
<INTEREST-EXPENSE>                            0                       0                       0
<INCOME-PRETAX>                        (213,732)               (797,117)                 14,302
<INCOME-TAX>                                  0                       0                       0
<INCOME-CONTINUING>                      11,323                   3,725                     913
<DISCONTINUED>                                0                       0                       0
<EXTRAORDINARY>                               0                       0                       0
<CHANGES>                                     0                       0                       0
<NET-INCOME>                           (213,732)               (797,117)               (114,593)
<EPS-BASIC>                               (.095)                  (.188)                  (.024)
<EPS-DILUTED>                             (.095)                  (.188)                  (.024)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission